CD44 and head and neck cancer: The assessment of overall more than 15000 gene expression analyses showed that head and neck cancers had elevated expression compared to the majority of other solid cancers, and also, that CD44 expression levels might decrease from application of culturing protocols (Figure 1 and Table 3).